AmerisourceBergen To Buy Theracom For $250 Million

Pharmaceutical services company AmerisourceBergen announced the signing of a definitive agreement to purchase Theracom a subsidiary of CVS Caremark for $250 million. The acquisition is expected to be neutral to fiscal year 2012 earnings, and slightly accretive in fiscal 2013.

Theracom, with an annualized revenues of around $700 million, provides a wide range of support to pharmaceutical and biotechnology drug manufacturers including consulting and reimbursement services and deal will be closed in the first quarter, ending December 31. The combination is expected to expand AmerisourceBergen's reimbursement, adherence and patient access services for pharmaceutical and biotech.

Theracom will join Lash Group as part of AmerisourceBergen Consulting Services. Lash Group and Theracom will offer an extensive platform of services and solutions to support the growing demand for patient access and reimbursement services, and support the need for unique distribution solutions.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis